Efficacy of the levonorgestrel-releasing intrauterine device in the treatment of recurrent pelvic pain in multitreated endometriosis

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 56, Issue 6, 2011, Pages 497-503

  Matorras, Roberto ^a,b,c   Ballesteros, Alejandro ^a,b,c   Prieto, Begoña ^a,b,c   Ocerin, Iratxe ^a,b,c   Expósito, Antonia ^a,b,c   Pijoan, José Ignacio ^a,b,c   Crisol, Lorena ^a,b,c  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Endometriosis; Intrauterine device; Levonorgestrel; Pelvic pain; Recurrence

Indexed keywords

LEVONORGESTREL;

ARTICLE; DRUG EFFICACY; ENDOMETRIOSIS; FOLLOW UP; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADICAL RESECTION; RECURRENT DISEASE; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, FEMALE; ENDOMETRIOSIS; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MIDDLE AGED; PAIN MEASUREMENT; PELVIC PAIN; PROSPECTIVE STUDIES; RECURRENCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 81355123887     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Matorras R, Rodriguez F, Pijoan JI, et al: Are there any clinical signs and symptoms that are related to endometriosis in infertile women? Am J Obstet Gynecol 1996;174:620-623
2. Giudence LC, Kao LC: Endometriosis. Lancet 2004;364:1789- 1799
3. Matorras R, Rodriguez F, Pijoan JI, et al: Women who are not exposed to spermatozoa and infertile women have similar rates of stage I endometriosis. Fertil Steril 2001;76:923-928
4. Matorras R, Rodriguez F, Pijoan JI, et al: Epidemiology of en-dometriosis in infertile women. Fertil Steril 1995;63:34-38
5. Hubacher D, Grimes DA: Noncontraceptive health benefits of intrauterine device: A systematic review. Obstet Gynecol Surv 2002;57:120-128
6. Bazot M, Cortez A, Darai E, et al: Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: Correlation with histopathology. Hum Reprod 2001;16:2427-2433
7. American Fertility Society: Revised American Fertility Society classification of endometriosis. Fertil Steril 1985;43:351- 352
8. Vercellini P, Frontino G, De Giorgi O, et al: Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for sympto- matic endometriosis: A pilot study. Fertil Steril 2003;80:305- 309
9. Schmidt CL: Endometriosis: A reappraisal of pathogenesis and treatment. Fertil Steril 1985;44:157-173
10. Redwine DB: Incidence of recurrent endometriosis remains unknown. Am J Obstet Gynecol 1984;149:804
11. Kikuchi I, Takeuchi H, Kitade M, et al: Recurrence rate of en-dometriomas following a laparoscopic cystectomy. Acta Ob-stet Gynecol Scand 2006;85:1120-1124
12. Wheeler JH, Malinak LR: Recurrent endometriosis: Incidence, management and prognosis. Am J Obstet Gynecol 1983;146:247-250
13. Abbott JA, Hawe J, Clayton RD, et al: The effects and effectiveness of laparoscopic excision of endometriosis: A prospective study with 2-5 year follow-up. Hum Reprod 2003; 1922-1927
14. Prentice A, Deary A, Goldbeck-Wood S, et al: Gonadotrophin-releasing hormone analogues for pain associated with endo-metriosis. Cochrane Database Syst Rev 1999;(1):CD000346
15. Luukkainen T, Lahteenmaki P, Toivonen J: Levonorgestrel-releasing intrauterine device. Ann Med 1990;22:85-90
16. Lockhat FB, Emembolu JE, Konje JC: Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel. Fertil Steril 2005;83:398-404
17. Lockhat FB, Emembolu JO, Konje JC: The efficacy, side effects and continuation rates in women with symptomatic en-dometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): A 3 year follow-up. Hum Reprod 2005;20:789-793
18. Vercellini P, Aimi G, Panazza S, et al: A levonorgestrel-releasing intrauterine system for the treatment of dysmenor-rhea associated with endometriosis: A pilot study. Fertil Steril 1999;72:505-508
19. de Sa Rosa e Silva AC, Rosa e Silva JC, Nogueira AA, et al: The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis. Fertil Steril 2006;86:742-744
20. Gomes MK, Ferriani RA, Rosa e Silva JC, et al: The levonorgestrel-releasing intrauterine system and endome-triosis staging. Fertil Steril 2007;87:1231-1234
21. Fedele L, Bianchi S, Zanconato G, et al: Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril 2001;75:485-488
22. Lockhat FB, Emembolu JO, Konje JC: The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endome-triosis and in the staging of the disease. Hum Reprod 2004; 19:179-184
23. Petta CA, Ferriani RA, Abrao MS, et al: Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005;20: 1993-1998